$RGBP Regen BioPharma Inc. (RGBP), (RGBPP), has provided an update on the status of its medicinal chemistry program being conducted by ChemDiv Inc., for the optimization of its lead compounds, RG-NA01, RG-NA02, RG-NI01 and RG-NI02. These compounds are small molecules and consist of activators (RG-NA01 and RG-NA02) and inhibitors (RG-NI01 and RG-NI02) of NR2F6. They were identified using Regen's patented screening methodology and unique chemical libraries.
https://finance.yahoo.com/news/regen-biopharm...00232.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!